Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BYCureus

Prediction Models Versus Fibrosis-4 Index (FIB-4) for Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Verification-Audited Systematic Review and Meta-Analysis

  • Syed Muhammad Hassan Bukhari1
  • Ushna Shahid2
  • Wahhaj Qayyum3
  • Aminah Amjad4
  • Salwa Qayyum5
  • Abdul Aleem6
6 affiliations
  1. 1Internal Medicine, South Tees Hospitals NHS Foundation Trust, Middlesbrough, GBR
  2. 2Internal Medicine, King's College Hospital, London, GBR
  3. 3Internal Medicine, James Cook University Hospital, Middlesbrough, GBR
  4. 4Internal Medicine, Combined Military Hospital (CMH) Lahore Medical College, National University of Medical Sciences (NUMS), Lahore, PAK
  5. 5Internal Medicine, Akhtar Saeed Medical & Dental College, Lahore, PAK
  6. 6Gastroenterology and Hepatology, County Durham and Darlington NHS Foundation Trust, Darlington, GBR
Read full textPDFCite

Related

  1. Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
    Mohammed Alfawaz, Dareen Bajamaan, Lama Alghamdi +7
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. GLP-1 receptor agonists in metabolic dysfunction-associated steatohepatitis: protocol for a systematic review and meta-analysis of randomized controlled trials
    Shi-ping Sun, Yan Fang, Li Liu +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-Analysis
    Panagiotis Theofilis, Paschalis Karakasis, Panayotis K. Vlachakis +7
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Effectiveness of eHealth lifestyle interventions on management of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
    Yangguo Zhao, Xinrui Yang, Yang Bai +2
    Nutrition & diabetesPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCDOAJ
  5. Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Incident Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Cohort Studies
    Disha Disha, Allah Rakhio Bhurgri, Deepak Verma +5
    CureusPeer-reviewedCC BYFull textCardiovascular medicineEurope PMCEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{bukhari2026prediction,
  title = {{Prediction Models Versus Fibrosis-4 Index (FIB-4) for Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Verification-Audited Systematic Review and Meta-Analysis}},
  author = {Syed Muhammad Hassan Bukhari and Ushna Shahid and Wahhaj Qayyum and Aminah Amjad and Salwa Qayyum and Abdul Aleem},
  journal = {Cureus},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13707609},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Prediction Models Versus Fibrosis-4 Index (FIB-4) for Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Verification-Audited Systematic Review and Meta-Analysis
AU  - Syed Muhammad Hassan Bukhari
AU  - Ushna Shahid
AU  - Wahhaj Qayyum
AU  - Aminah Amjad
AU  - Salwa Qayyum
AU  - Abdul Aleem
PY  - 2026
DA  - 2026/10/27
JO  - Cureus
UR  - https://europepmc.org/article/PMC/PMC13707609
SN  - 2168-8184
ER  -